Please login to the form below

ICS

This page shows the latest ICS news and features for those working in and with pharma, biotech and healthcare.

AZ prepares to file COPD triple, taking on rival GSK

The KRONOS trial of PT010 – which combines long-acting beta agonist (LABA) formoterol fumarate, long-acting muscarinic antagonist (LAMA) glycopyrronium and inhaled corticosteroid (ICS) budesonide – was presented at a medical congress ... triple –

Latest news

AZ rival to GSK’s COPD drug Anoro fails head-to-head test

The real battleground between the two companies is expected to be three-drug combinations for COPD, with an inhaled corticosteroid (ICS) added to the LAMA/LABA duo.
AZ’s COPD triple data sets up market clash with GSK

on LABA vilanterol, LAMA umeclidinium and ICS fluticasone furoate - in the US and Europe last year.
EMA approves GSK’s triple COPD therapy

moderate to severe COPD who are not adequately treated by the combination of an inhaled corticosteroid (ICS) and a long-acting beta agonist (LABA). ... The same indication was approved by the FDA in September, and makes Trelegy the first drug on the
With US approval, GSK now needs rapid uptake for COPD triple

The three-drug product delivers a long-acting beta agonist (LABA), a long-acting muscarinic antagonist (LAMA) and an inhaled corticosteroid (ICS) from a single device, and is the first product
GSK closes in on EU approval for triple COPD therapy

The new product adds long-acting muscarinic receptor antagonist (LAMA) umeclidinium to the ICS/LABA combination, which has proved so successful in GSK's big-selling Advair/Seretide (fluticasone propionate/salmeterol) ... The benefits of Trelegy/Elebrato -

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest Intelligence

NHS regional footprints

CCGs in action. In Nottinghamshire, six CCGs have joined forces to lead the strategic development of integrated care within the geographical area originally allocated to the Nottinghamshire ICS.
Deal Watch table for August 2014

600. TARIS Biomedical/ Allergan. Company acquisition. LiRIS for interstitial cystitis / bladder pain syndrome (IC/BPS) (phase II).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

What does the new NHS plan mean for pharma?

decade. The document, which will provide the basis for local NHS organisations’ plans, states that, by April 2021, all areas of England will be covered by an Integrated Care System (ICS), ... with typically one Clinical Commissioning Group (CCG) per
How can pharma engage with key stakeholders on NHS service transformation?

It should also be noted that in the 14 areas, which are early movers from STP to ICS/ICPPs (Integrated Care Provider Partnerships), former low-mid ranking CCG commissioners and project
How can pharma engage with key decision-makers in new, collaborative NHS care models?

This has resulted in an increasingly complex, multi-layered healthcare system that is seeing some GPs taking on wide-ranging responsibilities in Integrated Care System (ICS) areas. . ... work in an alliance within the ICS.
Managing local population needs is key for the NHS

year. These plans should “align key assumptions on income, expenditure, activity and workforce” and system leaders within the ICS are expected to take an “active role in this process”. ... efficiencies. . Conclusion . STPs and the newly
Large-scale NHS commissioning models require new partnership approach from pharma

Some of the mergers have been entered into voluntarily to help cut costs and ultimately pave the way for the introduction of Accountable or Integrated Care System (ACS/ICS) models; while

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Senior Medical Writer: Competitive salary and benefits

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Editor – Medical Education Agency – Bucks: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

PR Associate Director – Consumer Health & Beauty: Salary TBC

Senior Medical Writer: Salary TBC

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Director – Healthcare PR: Salary TBC

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Account Director, Medical Education: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...